Information for "Calyx (clinical research company)"
Basic information
| Display title | Calyx (clinical research company) |
| Default sort key | Calyx (clinical research company) |
| Page length (in bytes) | 2,597 |
| Namespace ID | 0 |
| Page ID | 72181242 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 2 |
| Counted as a content page | Yes |
| Wikidata item ID | Q123524125 |
| Local description | British–American biopharmaceutical company |
| Central description | American biopharmaceutical company |
| Page views in the past 30 days |
Page protection
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
Edit history
| Page creator | Fostera12 (talk | contribs) |
| Date of page creation | 16:30, 4 November 2022 |
| Latest editor | 146.115.148.50 (talk) |
| Date of latest edit | 15:05, 31 July 2024 |
| Total number of edits | 38 |
| Recent number of edits (within past 30 days) | 1 |
| Recent number of distinct authors | 1 |